"FDA Greenlights Portland Startup's Music Therapy for Stroke Recovery"
Originally Published 2 years ago — by Press Herald
The FDA has approved MedRhythms' neurorehabilitation system, InTandem, which uses sensors, software, and recorded music to help chronic stroke survivors regain their ability to walk. The system is based on the neuroscience of how rhythm engages parts of the brain responsible for movement. Feasibility studies have shown promising results for similar therapies that could potentially treat patients with Parkinson's disease and multiple sclerosis. InTandem allows patients to download an app loaded with MedRhythm's software and music, connect a sensor to their shoes, and start walking. The sensor measures the patient's walking characteristics and adjusts the tempo of the music, triggering a neurological response that helps the patient walk faster and more easily. The FDA listing is a major step in making this therapy more widely accessible.